🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

ESTREL trial at #ESOC2025: Levodopa did not boost motor recovery after stroke, but extensive ESTREL data may pave the way for exciting advances in personalized rehabilitation. The awakening of stroke rehabilitation might just be postponed! #Stroke #Rehab

Great to see the European Stroke Org European Stroke Master graduates active and joyful !

Back from #ESOC2025! ✨✨✨ What an incredible few days of learning, sharing, and connecting with the brightest minds in stroke research and care. So wonderful to be part of such great community! Here’s to continuing the momentum - until next time, #ESOC2026 See you in Maastricht

These guidelines are the result of an impressive collaborative effort involving module working group chairs, members and methodologists. As Co-chair of the ESO Guideline Board, it has been a privilege to support this process and witness the dedication of everyone involved. ⬇️

Prof. Maxime Baud #InselGruppe erhält den #MichaelPreis2025! Seine Forschung zeigt: epileptische Anfälle verlaufen zyklisch und sind vorhersagbar. Ein Meilenstein für Epilepsie-Patient:innen! Mehr: neurologie.insel.ch/de/aktuelles/d… #Neurotech #Epilepsie Faculty of Medicine, University of Bern

Essential reading for stroke specialists – the European Stroke Journal ICH Supplement From reversal strategies to post-ICH management—read the latest insights: 🔗 ow.ly/ZJ0s50VWrAC #ESOC2025 #StrokeCare #ICH #Neurology #VoiceOfStroke #StrokeTwitter

#ESOC2025 may be over, but the learning continues. Explore the full Abstract Book: ow.ly/7QIn50W3V9F Read the Best of Neurointervention & discover the most impactful abstracts in the field. Download or read as pdf: ow.ly/OJo850W3V9E #ESOC2025 #VoiceOfStroke #Stroke

Thank you to Professor Mitchell Elkind for an inspiring Cardio-Neuro lecture Stroke Research Center Bern on #atrial #cardiopathy! A brilliant overview of its role in stroke risk—and a call to rethink traditional paradigms. We're grateful for your insights and leadership in the field. 🫀🧠🙏🫶

News from the Swiss Stroke Registry by ⁦Martina Göldlin: DWI-lesions in ICH are frequent, already on admission before any intervention; associationbwith CAA and SVD burden. Suitable surrogate outcome in trials?Stroke Research Center Bern⁩ ⁦Neurology Journal⁩ neurology.org/doi/10.1212/WN…

Else C. Sandset providing insights to small vessel occlusion and the definition of minor stroke. Are they interchangeable? Decisive factor is the leven of disability. #EAN2025 #ESOguidelines

Diana Aguiar de Sousa referencing the #StrokeActionPlan at European Academy of Neurology Congress in Helsinki. Data shows that #EVT and #IVT rates still show major inequalities across Europe. How can we improve? Through strong networks, EMS and dedicated stroke units. #strokecare #EAN2025

Urs Martin Fischer presenting Distal Trial Medium Vessel Occlusion Trial and #discount trial which showed that #EVT did not improve the modifiable risk. More evidence and #stroketrials are needed. #stroketreatment #strokecare #EAN2025

A huge honor to be part at this EAN-ESO session with these great Speakers at #EAN2025 Thanks to European Academy of Neurology and European Stroke Org for the opportunity. I hope the participants liked it too. Azienda USL di Bologna

Collaboration on the optimal timing of anticoagulation after ischaemic stroke and atrial fibrillation: a systematic review and prospective individual participant data meta-analysis of randomised controlled trials (CATALYST) - The Lancet thelancet.com/journals/lance…

🚨 New in The Lancet: The CATALYST meta-analysis refines when to start anticoagulation after ischaemic stroke in #AF patients. Proud to see major contribution from Stroke Research Center Bern driving international stroke research forward! 🧠 sciencedirect.com/science/articl… Urs Martin Fischer UCL Stroke Research

🚨 Milestone reached 🚨 We have officially enrolled 50% of the patients in the #TECNO study 💿 Huge thanks to all participating centers, coordinators, and teams for your dedication and teamwork 🙏

Internationale Studie zeigt: Frühzeitige Blutverdünnung nach Schlaganfall ist sicher & wirksam. Patient:innen mit Vorhofflimmern profitieren deutlich – 30 % weniger Folge-Schlaganfälle. Mehr: neurologie.insel.ch/de/aktuelles/d… #InselGruppe #Schlaganfall #Neurologie Urs Martin Fischer

International study confirms early blood thinner treatment post-stroke is safe & effective. Patients with atrial fibrillation benefit – 30% fewer recurrent strokes. More: thelancet.com/journals/lance… #InselGruppe #Stroke #Neurology Urs Martin Fischer

Many thanks to all the CATALYST collaborators, who helped us to solve this old dilemma in acute stroke management: there is no reason to delay anticoagulants in ischemic stoke patients with atrial fibrillation! Insel Gruppe Stroke Research Center Bern Universität Bern

ICYMI: Collaboration on the optimal timing of anticoagulation after ischaemic stroke and atrial fibrillation: a systematic review and prospective individual participant data meta-analysis of randomised controlled trials (CATALYST) hubs.li/Q03v__D-0